COVID-19 pharmacotherapy utilization patterns during pregnancy: International Registry of Coronavirus Exposure in Pregnancy.

Whitney J WesthoffLouisa H SmithDiego F WyszynskiSonia Hernandez-Diaz

Published in: Pharmacoepidemiology and drug safety (2022)

IRCEP participants reported use of therapeutics for COVID-19 during pregnancy for which there is little safety information. Findings on COVID-19 pharmacotherapy utilization patterns can guide future studies examining the safety of COVID-19 therapies during pregnancy.

Keyphrases

sars cov
coronavirus disease
respiratory syndrome coronavirus
healthcare
smoking cessation
small molecule
preterm birth
social media
health information
pregnancy outcomes